Sars, Cov-II / Influenza A / Influenza B

Short description:

Hoc ornamentum est idoneam in vitro qualitative deprehendatur Sars-Cov-II, influenza A et Influenza B Nucleic Acidum in Nasopharyngeal Swab et Oropharyngeum Sars, Cov B. etiam potest esse in suspectum Pneumonia et suspected botrum portassent casibus et pro qualita Deprehensio et identify of Sars-Cov-II, Influenza A et Influenza B Nucleic Acidum in Nasopharyngeal Swab et Oropharyngeal Swab Exempla of Novel Coronavirus infectio in aliis.

Mitte inscriptio nobis

Product Detail

Product Tags

Product Name

HWTS-RT148-Sars-Cov-II / Influenza A / Influenza B Nucleic Acidum combined dependenda Kit (Fluorence PCR)

Channel

Nomen	PCR-MIX I	PCR-Nobis II
Fam Channel	Orf1ab gene	IVA
Vic / Hex	Internum	Internum
CYV	N gene	/
Rox Channel	E gene	Ivb

Technical parametri

Repono	-18 ℃
PLUTEUM-vitae	XII mensibus
Specimen Type	nasopharyngeal swabs et oropharyngeal swabs
Target	Sars-Cov-II tres peltas (Orf1ab, n et E genes) / influenza a / influenza b
Ct	≤38
CV	≤10.0%
LOD	Sars, Cov-II: CCC copies / ml A virus influenza: D copy / ml Influenza B virus: D copy / ml
Specifica	a) The cross test results showed that the kit was compatible with human coronavirus SARSr- CoV, MERSr-CoV, HcoV-OC43, HcoV-229E, HcoV-HKU1, HCoV-NL63, respiratory syncytial virus A and B, parainfluenza virus 1, II et III, rhinovirusa, B et C, adenovirus I: II, III, IV, V, VII et LV, humana metapneumovirus, Enterovirus A, B, C et D, Humanum Cytoplasmic Cytomegalovirus, Rotavirus, Virus Humanum Cytomegalovirus, Rotavirus, Virus, Mycoplasma Varicella, Mycoplasma Pneumoniae , Chlamydia Pneumoniae, Legionella, Pertussis, Haemophilus influenzae, Staphylococcus Aureus, Streptococcus pneumoniae, Streptococcus pyogenes, Klebsiella pneumoniae, Mycobacterium Pyococulosis, Aspergillus Fumigatus, Candida inter Pneumocystis Glabrata Yersini et Cryptocococcus noformans. b) anti interpellatio facultatem: Select mucin (60mg / ml), X% (v / v) humanum sanguinem, diphenymethylzoline (2mg / ml), sodium chloride (2mg), (20mg / ML), Beclomethasone (20mg / ml), dexamethasone (20mg/mL), flunisone (20μg/mL), triamcinolone acetonide (2mg/mL), budesonide (2mg/mL), mometasone (2mg/mL), fluticasone (2mg/mL), histamine hydrochloride (5mg/mL), α-interferon (800iu / ml), zanamivir (20mg/mL), ribavirin (10mg/mL), oseltamivir (60ng/mL), pramivir (1mg/mL), lopinavir (500mg/mL), ritonavir (60mg/mL), mupirocin (20mg/mL), azithromycin (1mg / ml) Ceprotene (40μg / ml) Meropenem (200mg / ml), levoflowacin (10μg / ml) et tobramycin (0.6mg / ml). Eventus ostendit quod impediente substantiae ad superius concentratione nihil intercessiones responsio ad deprehendatur results of pathogens.
COMPRESSUS	Applicari Biosystems (VII) D Real-vicis PCR Systems Applicari Biosystems (VII) D ieiunium realis-vicis PCR systems Slan^®-96p realis-vicis PCR systems QuantStudio ™ V Real-vicis PCR Systems LightCycler^®CDLXXX realis-vicis PCR ratio Linenene (IX) DC plus realis-vicis PCR deprehensio ratio MA-(VI) Real-vicis quantitatis scelerisque cycler BIOD CFX96 Real-vicis PCR ratio BIOD CFX Opus XCVI Real-vicis PCR ratio